$NANX
NANOPHASE TECHNOLOGIES Corp

2022 Q4 Form 10-Q Financial Statement

#000138713122011376 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $8.261M $9.678M $7.924M
YoY Change 12.17% 22.14% 103.81%
Cost Of Revenue $7.298M $7.185M $4.946M
YoY Change 17.77% 45.27% 124.72%
Gross Profit $963.0K $2.493M $2.978M
YoY Change -17.55% -16.29% 76.53%
Gross Profit Margin 11.66% 25.76% 37.58%
Selling, General & Admin $2.088M $2.279M $942.0K
YoY Change 131.49% 141.93% 29.04%
% of Gross Profit 216.82% 91.42% 31.63%
Research & Development $727.0K $848.0K $635.0K
YoY Change 28.67% 33.54% 56.79%
% of Gross Profit 75.49% 34.02% 21.32%
Depreciation & Amortization $154.0K $142.0K $118.0K
YoY Change 22.22% 20.34% 32.58%
% of Gross Profit 15.99% 5.7% 3.96%
Operating Expenses $2.815M $3.127M $1.577M
YoY Change 91.89% 98.29% 38.94%
Operating Profit -$1.852M -$634.0K $1.401M
YoY Change 519.4% -145.25% 153.8%
Interest Expense -$150.0K $116.0K -$38.00K
YoY Change 158.62% -405.26% -68.85%
% of Operating Profit -2.71%
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$2.002M -$750.0K $1.363M
YoY Change 460.78% -155.03% 216.98%
Income Tax -$17.00K
% Of Pretax Income
Net Earnings -$1.985M -$750.0K $1.363M
YoY Change 403.81% -155.03% 216.98%
Net Earnings / Revenue -24.03% -7.75% 17.2%
Basic Earnings Per Share -$0.02 $0.03
Diluted Earnings Per Share -$0.04 -$0.02 $26.87K
COMMON SHARES
Basic Shares Outstanding 49.23M shares 49.14M shares 48.57M shares
Diluted Shares Outstanding 49.17M shares 50.73M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.186M $510.0K $1.380M
YoY Change 232.72% -63.04% 21.69%
Cash & Equivalents $2.186M $510.0K $1.380M
Short-Term Investments
Other Short-Term Assets $866.0K $979.0K $698.0K
YoY Change -4.84% 40.26% 16.53%
Inventory $8.839M $9.596M $6.327M
Prepaid Expenses
Receivables $4.734M $5.368M $4.723M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.63M $16.45M $13.13M
YoY Change 43.33% 25.33% 69.0%
LONG-TERM ASSETS
Property, Plant & Equipment $7.949M $6.535M $5.693M
YoY Change 68.7% 14.79% 24.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.000K $6.000K $9.000K
YoY Change -25.0% -33.33% -18.18%
Total Long-Term Assets $16.93M $17.60M $5.702M
YoY Change 0.82% 208.61% 24.55%
TOTAL ASSETS
Total Short-Term Assets $16.63M $16.45M $13.13M
Total Long-Term Assets $16.93M $17.60M $5.702M
Total Assets $33.56M $34.05M $18.83M
YoY Change 18.19% 80.83% 52.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.363M $5.396M $2.436M
YoY Change 78.44% 121.51% 46.04%
Accrued Expenses $1.023M $1.347M $1.772M
YoY Change 8.14% -23.98% 67.49%
Deferred Revenue
YoY Change
Short-Term Debt $7.282M $5.358M $3.740M
YoY Change 439.01% 43.26% 83.24%
Long-Term Debt Due $0.00 $11.00K $1.137M
YoY Change -99.03% 65.74%
Total Short-Term Liabilities $16.84M $14.09M $9.473M
YoY Change 129.36% 48.78% 64.4%
LONG-TERM LIABILITIES
Long-Term Debt $1.000M $1.000M
YoY Change
Other Long-Term Liabilities $10.07M $11.54M $1.605M
YoY Change -9.97% 618.82% -18.86%
Total Long-Term Liabilities $11.07M $12.54M $0.00
YoY Change -18.51% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.84M $14.09M $9.473M
Total Long-Term Liabilities $11.07M $12.54M $0.00
Total Liabilities $27.91M $26.63M $11.09M
YoY Change 33.35% 140.16% 12.35%
SHAREHOLDERS EQUITY
Retained Earnings -$100.1M -$98.09M
YoY Change 2.69%
Common Stock $493.0K $492.0K
YoY Change 0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.649M $7.419M $7.741M
YoY Change
Total Liabilities & Shareholders Equity $33.56M $34.05M $18.83M
YoY Change 18.19% 80.83% 52.52%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.985M -$750.0K $1.363M
YoY Change 403.81% -155.03% 216.98%
Depreciation, Depletion And Amortization $154.0K $142.0K $118.0K
YoY Change 22.22% 20.34% 32.58%
Cash From Operating Activities $747.0K $984.0K -$219.0K
YoY Change -63.6% -549.32% -54.94%
INVESTING ACTIVITIES
Capital Expenditures $1.025M -$670.0K -$937.0K
YoY Change -338.93% -28.5% 444.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.025M -$670.0K -$937.0K
YoY Change 138.93% -28.5% 444.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.954M -468.0K 1.459M
YoY Change -183.29% -132.08% 7578.95%
NET CHANGE
Cash From Operating Activities 747.0K 984.0K -219.0K
Cash From Investing Activities -1.025M -670.0K -937.0K
Cash From Financing Activities 1.954M -468.0K 1.459M
Net Change In Cash 1.676M -154.0K 303.0K
YoY Change -331.81% -150.83% -147.42%
FREE CASH FLOW
Cash From Operating Activities $747.0K $984.0K -$219.0K
Capital Expenditures $1.025M -$670.0K -$937.0K
Free Cash Flow -$278.0K $1.654M $718.0K
YoY Change -111.21% 130.36% -328.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q3 us-gaap Other Income
OtherIncome
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
dei Entity Central Index Key
EntityCentralIndexKey
0000883107
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
nanx Conversion Of Convertible Loan Related Party
ConversionOfConvertibleLoanRelatedParty
usd
us-gaap Interest Paid
InterestPaid
usd
nanx Early Termination Of Operating Lease
EarlyTerminationOfOperatingLease
usd
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
usd
us-gaap Sublease Income
SubleaseIncome
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-22333
dei Entity Registrant Name
EntityRegistrantName
Nanophase Technologies Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-3687863
dei Entity Address Address Line1
EntityAddressAddressLine1
1319 Marquette Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Romeoville
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60446
dei City Area Code
CityAreaCode
630
dei Local Phone Number
LocalPhoneNumber
771-6708
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49232163 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
510000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
657000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
301000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
60000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5358000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1351000 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5368000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3937000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
9596000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6095000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
105000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1182000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
979000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
910000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
16453000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11599000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6535000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4712000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11056000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12075000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000 usd
CY2022Q3 us-gaap Assets
Assets
34050000 usd
CY2021Q4 us-gaap Assets
Assets
28394000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
589000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5396000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3566000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
800000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
783000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1347000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
946000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14094000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7340000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10740000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11700000 usd
CY2022Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
1000000 usd
CY2021Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
1000000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
569000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
661000 usd
CY2022Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
228000 usd
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
222000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12537000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13589000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24088 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24088 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49216180 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49216180 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48893573 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48893573 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
492000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
489000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
105012000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104423000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98085000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97447000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7419000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7465000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34050000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28394000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9678000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7924000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29056000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22110000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7185000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4946000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21659000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14588000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
2493000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
2978000 usd
us-gaap Gross Profit
GrossProfit
7397000 usd
us-gaap Gross Profit
GrossProfit
7522000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
848000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
635000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2310000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1670000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2279000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
942000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5493000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2994000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-634000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1401000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-406000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2858000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
116000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
38000 usd
us-gaap Interest Expense
InterestExpense
232000 usd
us-gaap Interest Expense
InterestExpense
1096000 usd
us-gaap Other Income
OtherIncome
952000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-750000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1363000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-638000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2714000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-750000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1363000 usd
us-gaap Net Income Loss
NetIncomeLoss
-638000 usd
us-gaap Net Income Loss
NetIncomeLoss
2714000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49174673 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48566431 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49068709 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43756300 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49174673 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50728431 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49068709 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45726300 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2732000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1310000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4084000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
78000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2019000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
41000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
6275000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
74000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1363000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7741000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7465000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
148000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
62000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7748000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
155000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
50000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7987000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7987000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
150000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-750000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7419000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7419000 usd
us-gaap Net Income Loss
NetIncomeLoss
-638000 usd
us-gaap Net Income Loss
NetIncomeLoss
2714000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
413000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
328000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
453000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
124000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
952000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
946000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
306000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
903000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1431000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1791000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3501000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1988000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
69000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
91000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1398000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
282000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
401000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
791000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-75000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-23000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-294000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-334000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2397000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
269000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1798000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1445000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1798000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1445000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
100000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
139000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1000000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25075000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19525000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
21068000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
17939000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
500000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
141000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
152000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4048000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1599000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-147000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
423000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
657000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
957000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
510000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1380000 usd
us-gaap Interest Paid Net
InterestPaidNet
232000 usd
us-gaap Interest Paid Net
InterestPaidNet
178000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
432000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28000 usd
nanx Conversion Of Convertible Loan Related Party
ConversionOfConvertibleLoanRelatedParty
2000000 usd
us-gaap Interest Paid
InterestPaid
19000 usd
nanx Early Termination Of Operating Lease
EarlyTerminationOfOperatingLease
73000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80E_eus-gaap--NatureOfOperations_zMzZzSS0SVhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2) <span id="xdx_820_zKjLzJQH6YXl">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nanophase Technologies Corporation (“Nanophase,” “Company,” “we,” “our,” or “us”) is a science-driven company which, along with its wholly owned subsidiary, Solésence, LLC (our “Solésence beauty science subsidiary”), is focused in various beauty- and life-science markets.  Using consumer health as our end-goal and science and innovation to guide the path, skin health and medical diagnostics combined currently make up the great majority of our business and drive our forward growth strategy.  We offer engineered materials, formulation development and commercial manufacturing through an integrated family of technologies. Our expertise in materials engineering allows us to effectively coat and disperse particles on a nano and “non-nano” scale for use in a variety of skin health markets, including for use in sunscreens as active ingredients and as fully developed prestige skin care and cosmetics products, marketed and sold through our Solésence beauty science subsidiary.  In terms of our life sciences focus, we have seen demand significantly decrease for our medical diagnostics ingredients during 2022. Additionally, we continue to sell products in legacy markets, including architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, and surface finishing technologies (polishing) applications, all of which, along with medical diagnostics, fall into the advanced materials product category.   </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> We target markets, primarily related to skin health products and ingredients, as well as diagnostic life sciences ingredients where we believe our materials and products offer practical and competitive minerals-based solutions. We traditionally work closely with current customers in these target markets to identify their material and performance requirements. We market our materials to various end-use applications manufacturers, and our Solésence® products to cosmetics and skin care brands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently developed technologies have made certain new products possible and opened potential new markets. During 2015 we were granted a patent on a new type of particle surface treatment (coating) — now called Active Stress Defense ™ Technology — which became the cornerstone of our new product development in personal care, with first revenue recognized during 2016. Active Stress Defense™ now refers to a suite of three proprietary technologies — Original Active Stress Defense™, Kleair™, and Bloom™ — all three of which either utilize a unique and proprietary, mineral-based technology or work synergistically with one of our unique and proprietary, mineral-based technologies to improve performance and/or aesthetics. Our ongoing innovation efforts include new IP in areas that advance environmental protection, align with market needs, and complement our existing technologies Through the creation of our Solésence beauty science subsidiary, we utilize our technology suite to manufacture and sell fully developed solutions to targeted customers in the skin care industry, typically in prestige skin care and cosmetics markets, in addition to the ingredients we have traditionally sold in the personal care area. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although our primary strategic focus has been the North American market, we currently sell materials to customers overseas and have been working to expand our reach within foreign markets. Our common stock trades on the OTCQB marketplace under the symbol NANX.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as “other revenue” in our Consolidated Statements of Operations, as it does not represent revenue directly from the sale of our products. </span></p>
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2932000 usd
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
411000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3937000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1444000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5368000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1369000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
179000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
295000 usd
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
507000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
264000 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1871000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1901000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2162000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1970000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-750000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1363000 usd
us-gaap Net Income Loss
NetIncomeLoss
-638000 usd
us-gaap Net Income Loss
NetIncomeLoss
2714000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49174673 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48566431 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49068709 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43756300 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2162000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1970000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49174673 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50728431 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49068709 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45726300 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
111000 usd
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
49000 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
218000 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1091000 usd
CY2022Q3 nanx Accrued Interest Expense Related Parties
AccruedInterestExpenseRelatedParties
39000 usd
CY2021Q3 nanx Accrued Interest Expense Related Parties
AccruedInterestExpenseRelatedParties
17000 usd
nanx Accrued Interest Expense Related Parties
AccruedInterestExpenseRelatedParties
39000 usd
nanx Accrued Interest Expense Related Parties
AccruedInterestExpenseRelatedParties
17000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6940000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4796000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2656000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1299000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
9596000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6095000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11056000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1182000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10740000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12075000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
589000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11700000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
8000 usd
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
30000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
41000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000 usd
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
15000 usd
CY2022Q3 nanx Lease Costs Finance
LeaseCostsFinance
9000 usd
CY2021Q3 nanx Lease Costs Finance
LeaseCostsFinance
17000 usd
nanx Lease Costs Finance
LeaseCostsFinance
34000 usd
nanx Lease Costs Finance
LeaseCostsFinance
56000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
377000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
144000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1115000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
434000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
152000 usd
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
31000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
484000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
91000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000 usd
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
83000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
32000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
125000 usd
us-gaap Sublease Income
SubleaseIncome
492000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
437000 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
186000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1190000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
557000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
446000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
203000 usd
us-gaap Lease Cost
LeaseCost
1224000 usd
us-gaap Lease Cost
LeaseCost
613000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
468000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
554000 usd
CY2022Q3 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P0Y2M12D
CY2021Q3 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P0Y10M24D
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P9Y
CY2021Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y2M12D
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.076 pure
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.093 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075 pure
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.141 pure
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
6000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
490000 usd
CY2022Q3 nanx Lease Liability Payments Due Year One
LeaseLiabilityPaymentsDueYearOne
496000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
6000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2050000 usd
CY2022Q3 nanx Lease Liability Payments Due Year Two
LeaseLiabilityPaymentsDueYearTwo
2056000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2025000 usd
CY2022Q3 nanx Lease Liability Payments Due Year Three
LeaseLiabilityPaymentsDueYearThree
2025000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1470000 usd
CY2022Q3 nanx Lease Liability Payments Due Year Four
LeaseLiabilityPaymentsDueYearFour
1470000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1468000 usd
CY2022Q3 nanx Lease Liability Payments Due Year Five
LeaseLiabilityPaymentsDueYearFive
1468000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8668000 usd
CY2022Q3 nanx Lease Liability Payments Due Year Thereafter
LeaseLiabilityPaymentsDueYearThereafter
8668000 usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
12000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16171000 usd
CY2022Q3 nanx Lease Liability Payment Due
LeaseLiabilityPaymentDue
16183000 usd
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4249000 usd
CY2022Q3 nanx Lease Imputed Interest
LeaseImputedInterest
4250000 usd
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
11000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11922000 usd
CY2022Q3 nanx Lease Liability
LeaseLiability
11933000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
47000 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
187000 usd
CY2021Q3 nanx Lease Liability Payments Due Year One
LeaseLiabilityPaymentsDueYearOne
234000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
109000 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
761000 usd
CY2021Q3 nanx Lease Liability Payments Due Year Two
LeaseLiabilityPaymentsDueYearTwo
870000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
6000 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
747000 usd
CY2021Q3 nanx Lease Liability Payments Due Year Three
LeaseLiabilityPaymentsDueYearThree
753000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
636000 usd
CY2021Q3 nanx Lease Liability Payments Due Year Four
LeaseLiabilityPaymentsDueYearFour
636000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
43000 usd
CY2021Q3 nanx Lease Liability Payments Due Year Five
LeaseLiabilityPaymentsDueYearFive
43000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2000 usd
CY2021Q3 nanx Lease Liability Payments Due Year Thereafter
LeaseLiabilityPaymentsDueYearThereafter
2000 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
162000 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2376000 usd
CY2021Q3 nanx Lease Liability Payment Due
LeaseLiabilityPaymentDue
2538000 usd
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
8000 usd
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
470000 usd
CY2021Q3 nanx Lease Imputed Interest
LeaseImputedInterest
478000 usd
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
154000 usd
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1906000 usd
CY2021Q3 nanx Lease Liability
LeaseLiability
2060000 usd
CY2022Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
3536000 usd
CY2021Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
3587000 usd
CY2022Q3 nanx Equipment Sale Net Book Value Equipment
EquipmentSaleNetBookValueEquipment
1.15 pure
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9678000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7924000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29056000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22110000 usd
CY2022Q3 nanx Cybertheft Loss
CybertheftLoss
188000 usd

Files In Submission

Name View Source Status
nanx-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001387131-22-011376-index-headers.html Edgar Link pending
0001387131-22-011376-index.html Edgar Link pending
0001387131-22-011376.txt Edgar Link pending
0001387131-22-011376-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nanx-10q_093022.htm Edgar Link pending
nanx-20220930.xsd Edgar Link pending
nanx-10q_093022_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nanx-20220930_def.xml Edgar Link unprocessable
nanx-20220930_pre.xml Edgar Link unprocessable
nanx-20220930_lab.xml Edgar Link unprocessable